SYBN:XETRA:XETRA-SPDR Barclays 10+ U.S. Corporate Bond UCITS (EUR)

ETF | Others |

Last Closing

USD 25.855

Change

+0.30 (+1.18)%

Market Cap

USD 0.10B

Volume

105.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing SYBN:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.03% 13% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.03% 13% F 21% F
Trailing 12 Months  
Capital Gain 11.10% 36% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.10% 36% F 40% F
Trailing 5 Years  
Capital Gain -20.21% 5% F 14% F
Dividend Return 8.72% 79% B- 48% F
Total Return -11.49% 13% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain -6.14% N/A N/A 10% F
Dividend Return -3.85% N/A N/A 14% F
Total Return 2.29% N/A N/A 75% C
Risk Return Profile  
Volatility (Standard Deviation) 6.76% N/A N/A 80% B-
Risk Adjusted Return -56.98% N/A N/A 11% F
Market Capitalization 0.10B 31% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.